Cargando…
Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
Colorectal cancer (CRC) represents the third most commonly diagnosed cancer and the second leading cause of cancer death worldwide. The modern concept of cancer biology indicates that cancer is formed of a small population of cells called cancer stem cells (CSCs), which present both pluripotency and...
Autores principales: | Silva, Valdenizia R., Santos, Luciano de S., Dias, Rosane B., Quadros, Claudio A., Bezerra, Daniel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696218/ https://www.ncbi.nlm.nih.gov/pubmed/34791817 http://dx.doi.org/10.1002/cac2.12235 |
Ejemplares similares
-
Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
por: Silva, Valdenizia R., et al.
Publicado: (2020) -
Emerging agents that target signaling pathways in cancer stem cells
por: Yang, Yue, et al.
Publicado: (2020) -
Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells
por: Brown, Geoffrey
Publicado: (2023) -
Xylopine Induces Oxidative Stress and Causes G(2)/M Phase Arrest, Triggering Caspase-Mediated Apoptosis by p53-Independent Pathway in HCT116 Cells
por: Santos, Luciano de Souza, et al.
Publicado: (2017) -
A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells
por: Silva, Valdenizia Rodrigues, et al.
Publicado: (2018)